Visit our COVID-19 Experts Directory to find UC San Diego sources who are available to discuss with the media the novel coronavirus, the COVID-19 illness and the societal impacts of the pandemic.
The Rady School of Management at the University of California San Diego has launched the Rady School Business Recovery Coalition to help businesses in the San Diego region navigate the unprecedented challenges faced by COVID-19.
Scientists with UC San Diego’s Jacobs School of Engineering and the Qualcomm Institute have developed a new gene prediction algorithm, called MINING-D, that could help researchers investigate the genetic clues behind the variation of symptoms shown in COVID-19 patients.
UC San Diego is in the advanced stages of executing a long-range development plan, with multiple construction projects underway to transform the university into a premier destination for students, patients, faculty, staff and the community.
The COVID-19 pandemic has ushered in remote work on an unprecedented scale. UC San Diego, like other employers and organizations around the globe, has had to pivot toward telework for staff and faculty members alike. Will this sudden transition shape the future of a new world of work?
It’s 7 p.m. when Stephanie Lichtwardt, R.N., receives a call from her 10-year-old son. She’s nearing the end of a 12-hour shift in the intensive monitoring unit at UC San Diego Medical Center. She worries. He doesn’t normally call at this time. She picks up.
Program makes COVID-19 testing available to thousands of students in effort to track the novel coronavirus and better position the campus to resume in-person activities in the fall.
With website, UC San Diego School of Medicine scientists will monitor health and well-being during and after pandemic.
UC San Diego Health now offers a telemedicine clinic to help patients with COVID-19 recover at home.
A team of researchers has developed a portable, more environmentally friendly method to produce hydrogen peroxide. It could enable hospitals to make their own supply of the disinfectant on demand and at lower cost.
UC San Diego scientists have launched a clinical trial to investigate whether a drug approved for treating high blood pressure might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.